Literature DB >> 16107976

Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003.

Heidi M Bauer1, Karen E Mark, Michael Samuel, Susan A Wang, Penny Weismuller, Douglas Moore, Robert A Gunn, Chris Peter, Ann Vannier, Nettie DeAugustine, Jeffrey D Klausner, Joan S Knapp, Gail Bolan.   

Abstract

BACKGROUND: Rates of fluoroquinolone-resistant Neisseria gonorrhoeae (QRNG) are increasing worldwide and in California.
METHODS: As a supplement to established surveillance, the investigation of QRNG in California included expanded surveillance in southern California, with in-depth interviews of patients (who had QRNG during the period of January 2001-June 2002) and a cross-sectional study of patients at 4 sexually transmitted diseases clinics with gonococcal isolates that underwent susceptibility testing (for the period of July 2001-June 2002).
RESULTS: The rate of QRNG increased from <1% in 1999 to 20.2% in the second half of 2003. The 2001-2002 expanded surveillance demonstrated that 66 (4.9%) of 1355 isolates were resistant to fluoroquinolones; the majority of these infections occurred after August 2001. Cross-sectional analysis of 952 patients with gonorrhea revealed that the prevalence of QRNG varied geographically during 2001-2002, with the highest rate being in southern California (8.9%) and the lowest being in San Francisco (3.6%). The QRNG prevalence was 8.6% among men who have sex with men (MSM), 5.1% among heterosexual men, and 4.3% among women. Although risk factors for QRNG varied by clinic, multivariate analysis demonstrated independent associations with race/ethnicity, recent antibiotic use, and MSM.
CONCLUSIONS: The emergence and spread of QRNG in California appeared to evolve from sporadic importation to endemic transmission among both MSM and heterosexuals. Monitoring of both the prevalence of and risk factors for QRNG infections is critical for making treatment recommendations and for developing interventions to interrupt transmission.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107976     DOI: 10.1086/432801

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

1.  Multidrug-resistant Neisseria gonorrhoeae.

Authors:  John Tapsall
Journal:  CMAJ       Date:  2009-02-03       Impact factor: 8.262

2.  Strain typing and antimicrobial resistance of fluoroquinolone-resistant Neisseria gonorrhoeae causing a California infection outbreak.

Authors:  Sheldon R Morris; Douglas F Moore; Paul B Hannah; Susan A Wang; Julia Wolfe; David L Trees; Gail Bolan; Heidi M Bauer
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

3.  Temporal trends in gonococcal population genetics in a high prevalence urban community.

Authors:  Marcos Pérez-Losada; Keith A Crandall; Jonathan Zenilman; Raphael P Viscidi
Journal:  Infect Genet Evol       Date:  2006-12-01       Impact factor: 3.342

4.  Antimicrobial resistant gonorrhea in Atlanta: 1988-2006.

Authors:  Jodie Dionne-Odom; Pradnya Tambe; Eileen Yee; Hillard Weinstock; Carlos del Rio
Journal:  Sex Transm Dis       Date:  2011-08       Impact factor: 2.830

5.  Real-time PCR assay for detection of quinolone-resistant Neisseria gonorrhoeae in urine samples.

Authors:  Mark J Siedner; Mark Pandori; Lina Castro; Pennan Barry; William L H Whittington; Sally Liska; Jeffrey D Klausner
Journal:  J Clin Microbiol       Date:  2007-01-31       Impact factor: 5.948

6.  Comparison of Antimicrobial Susceptibility of Urogenital Neisseria gonorrhoeae Isolates Obtained From Women and Men.

Authors:  Sarah Kidd; Page C Moore; Robert D Kirkcaldy; Susan S Philip; Harold C Wiesenfeld; John R Papp; Peter R Kerndt; Lalitha Venkatasubramanian; Khalil G Ghanem; Edward W Hook
Journal:  Sex Transm Dis       Date:  2015-08       Impact factor: 2.830

7.  The Neisseria gonorrhoeae biofilm matrix contains DNA, and an endogenous nuclease controls its incorporation.

Authors:  Christopher T Steichen; Christine Cho; Jian Q Shao; Michael A Apicella
Journal:  Infect Immun       Date:  2011-02-07       Impact factor: 3.441

8.  Prevalence of and risk factors for quinolone-resistant Neisseria gonorrhoeae infection in Ontario.

Authors:  Kaede V Ota; Frances Jamieson; David N Fisman; Karen E Jones; Itamar E Tamari; Lai-King Ng; Lynn Towns; Prasad Rawte; Alessandro Di Prima; Tom Wong; Susan E Richardson
Journal:  CMAJ       Date:  2009-02-03       Impact factor: 8.262

9.  Gonococcal cervicitis: a role for biofilm in pathogenesis.

Authors:  Christopher T Steichen; Jian Q Shao; Margaret R Ketterer; Michael A Apicella
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

10.  California Gonorrhea Surveillance System: Methodologic Aspects and Key Results of a Sample-Based System.

Authors:  Michael C Samuel; A Rain Mocello; Denise Gilson; K Jayne Bradbury; Gail Bolan
Journal:  Public Health Rep       Date:  2009       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.